[HTML][HTML] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery, W Rountree… - Immunity & …, 2023 - Springer
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery… - … & ageing: I & A, 2023 - pubmed.ncbi.nlm.nih.gov
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

[HTML][HTML] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery… - Immunity & …, 2023 - immunityageing.biomedcentral.com
Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated influenza vaccine
(HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared serum …

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial.

KE Schmader, CK Liu, B Flannery… - Immunity & …, 2023 - search.ebscohost.com
Background: Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

[HTML][HTML] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery… - Immunity & Ageing …, 2023 - ncbi.nlm.nih.gov
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery… - Immunity and …, 2023 - search.proquest.com
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

[PDF][PDF] Immunogenicity of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial

KE Schmader, CK Liu, B Flannery, W Rountree… - assets-eu.researchsquare.com
Background Adjuvanted inactivated in uenza vaccine (aIIV) and high-dose inactivated in
uenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

Immunogenicity of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial

KE Schmader, CK Liu, B Flannery, W Rountree… - 2022 - researchsquare.com
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

K Schmader, C Liu, B Flannery, W Rountree… - Immunity & Ageing …, 2023 - europepmc.org
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …

[PDF][PDF] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

KE Schmader, CK Liu, B Flannery, W Rountree… - 2023 - immunityageing.biomedcentral.com
Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated
influenza vaccine (HD-IIV) are US-licensed for adults aged≥ 65 years. This study compared …